Výsledky vyhledávání

Abstract PD2-14: Participation in a personalized breast cancer screening trial does not increase anxiety at baseline

Autor: E Laura, Thomas Cink, A Stover-Fiscalini, Neil S. Wenger, Christina Yau, L.J. van 't Veer, Martin Eklund, Arash Naeim, Karen Sepucha, Bev Parker, Alexander D. Borowsky, Antonia Petruse, K Adduci, S Annette, Wisdom Advocate Partners, Hoda Anton-Culver, S Sarrafan, Andrea Z. LaCroix, Lisa Madlensky

Publikováno v: Cancer Research. 78:PD2-14

Introduction: The purpose of this study is to examine whether participation in a personalized screening trial is associated with anxiety or breast cancer worry. The Patient Centered Outcomes Research Institute recently funded WISDOM (Women Informed t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7e1a6ea5749d75d999d202ab6bea9dda
https://doi.org/10.1158/1538-7445.sabcs17-pd2-14

Zobrazit plný text záznamu

Abstract OT3-03-01: Preference-Tolerant randomized trial of risk-based vs. annual breast cancer screening: WISDOM study in progress

Publikováno v: Cancer Research. 78:OT3-03

Purpose: Women Informed to Screen Depending on Measures of risk (WISDOM) trial is a pragmatic study comparing two real world approaches to clinical care for breast screening: annual screening versus personalized screening. The novelty of the personal

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::140533d2da769d095409aff191fe33b7
https://doi.org/10.1158/1538-7445.sabcs17-ot3-03-01

Zobrazit plný text záznamu

Abstract P5-02-03: Evaluating the feasibility of a web-based preference-tolerant randomized trial of risk-based vs. annual breast cancer screening: WISDOM study pilot

Autor: S Sarrafan, Sarah Theiner, Sarah Rosenberg-Wohl, Hoda Anton-Culver, April S. Liang, Alexander D. Borowsky, Advocate Partners, S Sawyer, LJ Esserman, D Gordon, A Stover Fiscalini, Thomas Cink, Miya Frick, Andrea Z. LaCroix, Arash Naeim, Celia P. Kaplan, L van 't Veer

Publikováno v: Cancer Research. 77:P5-02

Background: The WISDOM Study (Women Informed to Screen Depending on Measures of risk) aims to examine the effectiveness of personalized breast cancer screening and to bring objective recommendations to the current mammography screening debate. The WI

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::af6e124097447ebc32c5fa7394e7aead
https://doi.org/10.1158/1538-7445.sabcs16-p5-02-03

Zobrazit plný text záznamu

Case report of papillary breast carcinoma, cystic

Autor: Susan, Anderson, Thomas, Cink

Publikováno v: South Dakota medicine : the journal of the South Dakota State Medical Association. 66(7)

Intracystic papillary carcinoma of the breast (ICP) is a rare form of noninvasive breast cancer. The average age of onset is 65 years. Patients with ICP have a greater than 15-year survival rate advantage compared to patients with other breast carcin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::15fdfa261ffdd08dde52bcd2bed9f7ac
https://pubmed.ncbi.nlm.nih.gov/23957111

Zobrazit plný text záznamu

Abstract 2623: Common genetic variants associated with breast cancer risk used in the Athena study to enhance models identifying women for breast cancer chemoprevention

Autor: Sarah Theiner, Alexandra S. Perry, Thomas Cink, Laura van 't Veer, Paige Kendall, Elad Ziv, S Sawyer, Laura J. Esserman, David A. Pearce, Scott Huntsman, J Tice, Denise M. Wolf, B Pan

Publikováno v: Cancer Research. 76:2623-2623

Background: The U.S. Preventive Services Task Force recommends that women with a >3% five-year risk of developing breast cancer consider taking selective estrogen receptor modifiers (SERMs) or aromatase inhibitors (AIs) to reduce their risk. Polygeni

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::59926adb5d3da4cad9bcd48e67e594be
https://doi.org/10.1158/1538-7445.am2016-2623

Zobrazit plný text záznamu

The WISDOM study pilot: Evaluating a preference-tolerant RCT of risk-based vs. annual breast cancer screening

Autor: April S. Liang, Laura J. Esserman, Sarah Theiner, Sarah Rosenberg-Wohl, Alexander D. Borowsky, Hoda Anton-Culver, Julissa Cabrera, Jeffrey A. Tice, Allison Stover Fiscalini, Emily C. Wong, Andrea Z. LaCroix, Celia P. Kaplan, Setareh Sarrafan, Laura J. van't Veer, Miya Frick, Arash Naeim, Elad Ziv, Thomas Cink, S Sawyer

Publikováno v: Journal of Clinical Oncology. 34:e13035-e13035

e13035Background: The goal of the WISDOM study (Women Informed to Screen Depending on Measures of risk) is to examine the effectiveness of a personalized approach to breast cancer screening and to bring clarity and objective recommendations to the cu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b161e01508cd3c6452070bd6f468ee92
https://doi.org/10.1200/jco.2016.34.15_suppl.e13035

Zobrazit plný text záznamu

Women informed to screen depending on measures of risk (WISDOM): A RCT of personalized vs. annual screening for breast cancer

Publikováno v: Journal of Clinical Oncology. 34:TPS1594-TPS1594

TPS1594Background: Currently in the United States, the majority of women are recommended to undergo annual mammographic screening for breast cancer starting at age 40, regardless of personal risk. ...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f95dff796d63ed81ddc951cc9170b199
https://doi.org/10.1200/jco.2016.34.15_suppl.tps1594

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání